Literature DB >> 22836227

Serotonin modulation of cerebral glucose metabolism: sex and age effects.

Cynthia A Munro1, Clifford I Workman, Elisse Kramer, Carol Hermann, Yilong Ma, Vijay Dhawan, Thomas Chaly, David Eidelberg, Gwenn S Smith.   

Abstract

The serotonin system is implicated in a variety of psychiatric disorders whose clinical presentation and response to treatment differ between males and females, as well as with aging. However, human neurobiological studies are limited. Sex differences in the cerebral metabolic response to an increase in serotonin concentrations were measured, as well as the effect of aging, in men compared to women. Thirty-three normal healthy individuals (14 men/19 women, age range 20-79 years) underwent two resting positron emission tomography studies with the radiotracer [18F]-2-deoxy-2-fluoro-D-glucose ([(18)F]-FDG) after placebo and selective serotonin reuptake inhibitor (SSRI, citalopram) infusions on two separate days. Results indicated that women demonstrated widespread areas of increased cortical glucose metabolism with fewer areas of decrease in metabolism in response to citalopram. Men, in contrast, demonstrated several regions of decreased cortical metabolism, but no regions of increased metabolism. Age was associated with greater increases in women and greater decreases in men in most brain regions. These results support prior studies indicating that serotonin function differs in men and women across the lifespan. Future studies aimed at characterizing the influences of age and sex on the serotonin system in patients with psychiatric disorders are needed to elucidate the relationship between sex and age differences in brain chemistry and associated differences in symptom presentation and treatment response.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22836227      PMCID: PMC3440524          DOI: 10.1002/syn.21590

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  50 in total

1.  A 18F-MPPF PET normative database of 5-HT1A receptor binding in men and women over aging.

Authors:  Nicolas Costes; Isabelle Merlet; Karine Ostrowsky; Isabelle Faillenot; Franck Lavenne; Luc Zimmer; Philippe Ryvlin; Didier Le Bars
Journal:  J Nucl Med       Date:  2005-12       Impact factor: 10.057

2.  The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients.

Authors:  G S Alexopoulos; I R Katz; C F Reynolds; D Carpenter; J P Docherty
Journal:  Postgrad Med       Date:  2001-10       Impact factor: 3.840

3.  Parametric and regional maps of free serotonin 5HT1A receptor sites in human brain as function of age in healthy humans.

Authors:  Mette Møller; Steen Jakobsen; Albert Gjedde
Journal:  Neuropsychopharmacology       Date:  2007-01-24       Impact factor: 7.853

4.  Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory.

Authors:  Randy L Buckner; Abraham Z Snyder; Benjamin J Shannon; Gina LaRossa; Rimmon Sachs; Anthony F Fotenos; Yvette I Sheline; William E Klunk; Chester A Mathis; John C Morris; Mark A Mintun
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

5.  A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria.

Authors:  Hristina Jovanovic; Asta Cerin; Per Karlsson; Johan Lundberg; Christer Halldin; Anna-Lena Nordström
Journal:  Psychiatry Res       Date:  2006-11-07       Impact factor: 3.222

6.  Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimer's disease.

Authors:  Ying Liu; Mi-Jeong Yoo; Alena Savonenko; Wanda Stirling; Donald L Price; David R Borchelt; Laura Mamounas; W Ernest Lyons; Mary E Blue; Michael K Lee
Journal:  J Neurosci       Date:  2008-12-17       Impact factor: 6.167

7.  Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET.

Authors:  Hristina Jovanovic; Johan Lundberg; Per Karlsson; Asta Cerin; Tomoyuki Saijo; Andrea Varrone; Christer Halldin; Anna-Lena Nordström
Journal:  Neuroimage       Date:  2007-10-25       Impact factor: 6.556

8.  The serotonin-1A receptor distribution in healthy men and women measured by PET and [carbonyl-11C]WAY-100635.

Authors:  Patrycja Stein; Markus Savli; Wolfgang Wadsak; Markus Mitterhauser; Martin Fink; Christoph Spindelegger; Leonhard-Key Mien; Ulrike Moser; Robert Dudczak; Kurt Kletter; Siegfried Kasper; Rupert Lanzenberger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-06-10       Impact factor: 9.236

9.  5-HT(1A) receptor and 5-HTT binding during the menstrual cycle in healthy women examined with [(11)C] WAY100635 and [(11)C] MADAM PET.

Authors:  Hristina Jovanovic; Per Karlsson; Asta Cerin; Christer Halldin; Anna-Lena Nordström
Journal:  Psychiatry Res       Date:  2009-01-01       Impact factor: 3.222

10.  Brain regional alpha-[11C]methyl-L-tryptophan trapping, used as an index of 5-HT synthesis, in healthy adults: absence of an age effect.

Authors:  Pedro Rosa-Neto; Chawki Benkelfat; Yojiro Sakai; Marco Leyton; Jose A Morais; Mirko Diksic
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-02-21       Impact factor: 10.057

View more
  5 in total

1.  Functional t1ρ imaging in panic disorder.

Authors:  Vincent A Magnotta; Casey P Johnson; Robin Follmer; John A Wemmie
Journal:  Biol Psychiatry       Date:  2013-10-21       Impact factor: 13.382

Review 2.  Evaluating the evidence for sex differences: a scoping review of human neuroimaging in psychopharmacology research.

Authors:  Korrina A Duffy; C Neill Epperson
Journal:  Neuropsychopharmacology       Date:  2021-11-03       Impact factor: 7.853

3.  Longitudinal progression of cognitive decline correlates with changes in the spatial pattern of brain 18F-FDG PET.

Authors:  Sepideh Shokouhi; Daniel Claassen; Hakmook Kang; Zhaohua Ding; Baxter Rogers; Arabinda Mishra; William R Riddle
Journal:  J Nucl Med       Date:  2013-07-17       Impact factor: 10.057

4.  Evaluation of heritable determinants of blood and brain serotonin homeostasis using recombinant inbred mice.

Authors:  R Ye; A M D Carneiro; D Airey; E Sanders-Bush; R W Williams; L Lu; J Wang; B Zhang; R D Blakely
Journal:  Genes Brain Behav       Date:  2013-10-31       Impact factor: 3.449

5.  Sex differences in depressive symptoms and tolerability after treatment with selective serotonin reuptake inhibitor antidepressants: Secondary analyses of the GENPOD trial.

Authors:  Marilia Gougoulaki; Glyn Lewis; David J Nutt; Tim J Peters; Nicola J Wiles; Gemma Lewis
Journal:  J Psychopharmacol       Date:  2021-02-26       Impact factor: 4.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.